UXX-15526-08309
4 vaccinations
4 coded responses
19 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 941 / CA
- Registered
- 2021-09-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Dose 1 — Pfizer-BioNTech
-
2021-02-26
Dose 2 — Pfizer-BioNTech
-
2021-09-27
Registered in v-safe
-
2021-09-28
Dose 3 — Pfizer-BioNTech
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Joint pains · Be unable to work or attend schoolAdult check-in
- 2021-10-01
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: Poor · Headache, Muscle or body aches, Fatigue or tirednessFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: FairFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
- 2021-10-07
- 2021-10-12
- 2021-10-19
- 2021-10-28
- 2021-11-02
- 2021-11-09
- 2021-12-28
- 2022-03-31
-
2022-05-06
Dose 4 — Moderna
- 2022-05-14
- 2022-05-29
- 2022-06-05
- 2022-06-12
- 2022-08-07
-
2022-11-04
Survey response — 6 months, dose 4MedDRA: Fatigue, Oropharyngeal pain, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sneezing, runny nose, fatigue, sore throatMedDRA releases: 2024-11 · check-in free text available
-
2023-05-06
Survey response — 12 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-05-06
Report sent to call center — 12 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-05-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Pfizer-BioNTech | No |
| 2 | 2021-02-26 | Pfizer-BioNTech | No |
| 3 | 2021-09-28 | Pfizer-BioNTech | No |
| 4 | 2022-05-06 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-05-06 | Unsuccessful |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Sore throat
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Sore throat
Release 12 — 6 months, dose 4
Symptoms: Sneezing, runny nose, fatigue, sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release